Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | CancerVax - |
Description | Developing a Breakthrough Universal Cancer About Pipeline Market Newsroom Podcast Investors Contact Developing a Breakthrough Universal Cancer Vaccine Using the body’s immune system to fight cancer |
Keywords | N/A |
WebSite | cancervax.com |
Host IP | 208.109.72.104 |
Location | United States |
Site | Rank |
US$267,672
Last updated: 2023-05-04 10:51:40
cancervax.com has Semrush global rank of 39,542,155. cancervax.com has an estimated worth of US$ 267,672, based on its estimated Ads revenue. cancervax.com receives approximately 30,886 unique visitors each day. Its web server is located in United States, with IP address 208.109.72.104. According to SiteAdvisor, cancervax.com is safe to visit. |
Purchase/Sale Value | US$267,672 |
Daily Ads Revenue | US$248 |
Monthly Ads Revenue | US$7,413 |
Yearly Ads Revenue | US$88,950 |
Daily Unique Visitors | 2,060 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cancervax.com. | A | 7199 | IP: 208.109.72.104 |
cancervax.com. | NS | 3600 | NS Record: ns02.domaincontrol.com. |
cancervax.com. | NS | 3600 | NS Record: ns01.domaincontrol.com. |
cancervax.com. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.com. |
cancervax.com. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
cancervax.com. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
cancervax.com. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
cancervax.com. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
cancervax.com. | TXT | 3600 | TXT Record: v=spf1 include:dc-aa8e722993._spfm.cancervax.com ~all |
cancervax.com. | TXT | 3600 | TXT Record: google-site-verification=WxlAjkcp8HExvdq3O26tuYLO3HHzkebI3VJ3Vo1mkhU |
About Pipeline Market Newsroom Podcast Investors Contact Developing a Breakthrough Universal Cancer Vaccine Using the body’s immune system to fight cancer Watch video Being Developed At SUBSCRIBE Keep up with our progress by subscribing to our email newsletter! Subscribe --> CancerVax redefining immunotherapy Pre-clinical. We’re developing cutting edge immunotherapy cancer treatments that use the body’s immune system to fight cancer. Universal Cancer Vaccine Universal Cancer Vaccine We are developing a Universal Cancer Vaccine (UCV) that will use the body’s own immune system to target and eliminate cancer cells. The UCV will use cutting edge bioengineering and molecular technologies to uniquely detect, mark and kill only cancer cells. By forcing cancer cells to express a unique marker that healthy cells do not have, custom antibody drugs and the body’s immune system can target and destroy them with precision. Additionally, we intend to make cancer cell look like common diseases so |
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Oct 2021 12:55:14 GMT Server: Apache Location: https://cancervax.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 x-powered-by: PHP/7.4.23 content-type: text/html; charset=UTF-8 date: Tue, 26 Oct 2021 12:55:14 GMT server: Apache |
Domain Name: CANCERVAX.COM Registry Domain ID: 1706425377_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-03-17T01:02:43Z Creation Date: 2012-03-09T19:31:33Z Registry Expiry Date: 2022-03-09T18:31:33Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T13:07:05Z <<< |